Skip to content
  • Sunday, 26 July 2026
  • 1:43 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • High-Dose Fish Oil Supplements Fail to Slow Cognitive Decline in Older Adults at Risk for Alzheimer’s Disease Despite Successful Brain Penetration
Neuroscience & Brain Research

High-Dose Fish Oil Supplements Fail to Slow Cognitive Decline in Older Adults at Risk for Alzheimer’s Disease Despite Successful Brain Penetration

Rifan Muazin Jun 30, 2026 0

The multi-billion-dollar global industry built around omega-3 fatty acid supplements has faced a significant scientific setback following the release of…

Read More
Neuroscience & Brain Research

New Research Suggests Fish Oil Supplements May Impede Brain Recovery Following Repeated Traumatic Injuries

Rifan Muazin Apr 26, 2026 0

The Medical University of South Carolina (MUSC) has released a groundbreaking study that challenges the long-standing perception of fish oil…

Read More
Python Project Setup 2026: uv + Ruff + Ty + PolarsSingulonics and the Breakthrough of Narwhal-Shaped Wavefunctions in Dielectric NanophotonicsPharma 50: The 50 best-selling drugs of FY2025Record-Breaking 220 PeV Cosmic Neutrino Detection Points to Blazars as Supreme Galactic Accelerators
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ